BIO-RAD LABORATORIES -CL B
BIO.BNYSE🏆 #803 by market capEarnings Oct 27 · PostUS Equity
$298.50▲ $9.58 (+3.21%)
Pre-market · at close1h—
24h▲ 3.2%
7d▲ 0.0%
14d▲ 0.0%
30d▲ 0.0%
1y—
🏦Market Cap
$7.99B
Small Cap
📈Revenue Growth (YoY)
+1.4%
Slowing
📊Gross Margin
51.9%
Healthy
💵FCF Margin
13.6%
Healthy
⚖️P/S Ratio
3.6x
Fair
Otter Score
45
Weak
Earnings
Q2 · 2026After-MarketReported 2026-08-04Earnings Per Share
Actual
2.62
Expected
1.77
beat
+48.40%
Revenue
Actual
$651.00M
Expected
$630.23M
beat
+3.30%
Consensus estimates